SHEPHERDSTOWN, W.Va. — A groundbreaking pilot study conducted by researchers from Shepherd University has been accepted for publication in the esteemed journal Photobiomodulation, Photomedicine and Laser Surgery.
Drs. Jennifer Flora and Kelly Watson Huffer co-authored “Transcranial Photobiomodulation Therapy as an Intervention for Opioid Cravings and Depression: A Pilot Cohort Study,” which explores the potential of photobiomodulation (PBM) therapy for opioid use disorder.
"This study examines the impact of PBM on reducing opioid cravings and depressive symptoms among individuals undergoing treatment for opioid addiction at a rehabilitation center in West Virginia," Flora said.
Phase I of the study involved participants from a Jefferson County-based recovery facility undergoing bi-weekly therapy sessions using a SunPower LED helmet emitting near-infrared light at an 810 nm wavelength, which Flora says is key.
“At that wavelength, light penetrates brain tissues to stimulate recovery and improve neurological function," she said. "The study showed significant reductions in the intensity, duration and frequency of opioid cravings, as well as notable improvements in depressive symptoms."
Shepherd University President Dr. Mary J.C. Hendrix said the work being done at Shepherd could impact the entire country.
“We are delighted that this important study will receive the attention it deserves,” Hendrix said. “Opioid Use Disorder is a critical concern nationwide, but especially here in West Virginia. I am very proud that researchers at Shepherd University are leading the way with new treatment strategies to help individuals recover.”
Hendrix invited local and state officials to the Shepherd campus in May 2024 to announce phase II of the study, which involves participants at a recovery facility in Berkeley County, W.Va. and is already underway.
Flora said they are optimistic about the future of their work.
"We hope to recreate our findings from Phase I as we continue exploring this innovative therapy in larger, more diverse cohorts to optimize treatment protocols," Flora said.
This study is the first global transcranial study focusing on PBM and opioid use disorder.
The potential of Flora and Watson Huffer's work continues to gain recognition.
On July 17, they presented their findings to the Berkeley County-based Martinsburg Initiative, a partnership between police, schools, community, health and education seeking to break the cycle of substance abuse.
Meritus receives initial accreditation to offer psychiatry residency in 2025
This article originally appeared on The Herald-Mail: Shepherd University researchers' innovative opioid study accepted for publication
Most Popular
Comments / 0